Member Info for parmxz

@bald_eagle, there are many medicines which are being sold OTC and no one knows how they really work. But what we know is they are safe and they work. And some of them are found accidentally. One best example minoxidil - its market size 1077.81 Million USD By The End Of 2025. Durg which being worked out for heart related issues is working for controlling baldness.

No chance of FCA going soft on Metro due to Corona crisis?

However, according to a 2012 amendment of section 513(f)2 of the Federal Food, Drug, and Cosmetic Act, device manufacturers can apply for a de novo classification for a low- to moderate-risk device without submitting a 510(k).

For people who wanted to understand the application process and technical details about - De Novo Classification. IMHO, it looks exremely promising and quicker route.

As part of the Food and Drug Administration Modernization Act of 1997, the de novo classification pathway functions as an alternative means of classifying low- to moderate-risk devices. Traditionally, these devices were automatically classified as class III devices after the Food and Drug Administration determined that they are not substantially equivalent during review of a 510(k) application.
However, according to a 2012 amendment of section 513(f)2 of the Federal Food, Drug, and Cosmetic Act, device manufacturers can apply for a de novo classification for a low- to moderate-risk device without submitting a 510(k).

https://www.thefdagroup.com/blog/2015/08/what-is-a-de-novo-classification/

Futura Medical CEO talks regulatory timeline and commercial potential for breakthrough gel
https://www.youtube.com/watch?v=-ilHI1j-QOw

@BCB, I doubt about extremely positive news. It would be probably positive news or reiteration of earlier +ve news about Dermasys working with more some scientific details. The stock is under-valued.

No, actually L1PTU joined to learn about FUM to invest his moneies as per his very first post :)

It could be institutional investor (buying ). When I try from my broker (IG), I am unable to find out quote for 190K. For 50K, the buy price is 13.73 and sell price is 11p.

@Lord - FUM to reassure its shareholders ?? Companies don't work to reassurre the shareholders. They work what they are supposed to and update the market when the information is deemed to be an RNS.

Lombard Odier increased again. They are slowly building massive when the price is low.

@frankmu, about your comment - news about TPR are due by the end of the month. I don't think RNS would be issued for that. I might be wrong. They may have already submitted the lab work to the regulatory. Same thing happened with other Pharma compancy recently (Faron). They had something going with FDA and RNS was not issued.

@Italian, some of them can be investigated and charged for market abuse. The kind of infomration the cater is rubbish and misleading. They don't check the RNSs, don't believe in experts in the field and don't even know how to find scinetific information. Irrespective of weather Futura succeeds or not, the factual information is out there. When we rebut with factual information, they simply ignore and don't reply. When there is dip in the share price, they rush here with their scaremongering devious assertions.

Sorry for my ingnorance. Anyone know why it is spiking without any RNS or news? Or is news expected?

Franny1968, is it restricted in the UK or only with your SIPP provider? I do day trade, never found any restriction.

@PATTSV, since they are going devive route which doesn't have chemical action, chances of FDA requiring another trail are slim. The only concern we heard from KJ is that FDA doesn't want the efficacy of the ED treament concealing the underlying health issues such as heart prolbem and etc. They may advise the same instructions that have been advised for other ED treatments already available.

Doesn't resemble to "looking to invest a few grand" story?

Thats plenty. Now they have 20.66%. Some muppet was saying yesterday that lombard is going to dump.

IMHO, this stock is over sold, MED3000 results were misundertood. Other than MED3000 - TPR100, TIB200 and CBD100. Plenty of news ..awaiting.

Lol baldy. See you in the court? Seriously? Anyone with some rational mind will find you in trouble in the court for all the twisting and misinfomration you have been spreading.

Serious investors go by the RNS and the hard data. You guys ridicule the mirror article and use the same article to carry on with devious assertions.
My suggestion / opinion
- read the RNS
- read the data
- listen to the experts in the field
- don't spread the lies like Ralph talking positive because he is being paid.
- finally close your shorts to save money.